Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information
12 Months Ended
Dec. 31, 2019
Document And Entity Information  
Entity Registrant Name Can-Fite BioPharma Ltd.
Entity Central Index Key 0001536196
Document Type 20-F
Document Period End Date Dec. 31, 2019
Amendment Flag false
Current Fiscal Year End Date --12-31
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2019
Entity a Well-known Seasoned Issuer No
Entity a Voluntary Filer No
Entity Current Reporting Status Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 120,652,683
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-36203
Entity Interactive Data Current Yes
Entity Incorporation State Country Code L3